Zura Bio Limited Stock Performance
| ZURA Stock | 1.67 0.28 20.14% |
The firm maintains a market beta of 1.43, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Zura Bio will likely underperform. At this point, Zura Bio Limited has a negative expected return of -0.17%. Please make sure to check out Zura Bio's accumulation distribution, as well as the relationship between the day typical price and relative strength index , to decide if Zura Bio Limited performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Zura Bio Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
1 | Zura Bio to Present at the Leerink Partners Global Healthcare Conference | 02/24/2025 |
2 | Acquisition by Davis Kim of 488800 shares of Zura Bio at 1.2 subject to Rule 16b-3 | 02/27/2025 |
3 | Acquisition by Nistala Kiran of 341700 shares of Zura Bio at 1.2 subject to Rule 16b-3 | 03/03/2025 |
4 | Rhumbline Advisers Has 94,000 Stock Position in Zura Bio Limited - Defense World | 03/11/2025 |
5 | Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates | 03/25/2025 |
6 | Zura Bio Issues Earnings Results | 03/27/2025 |
7 | After losing 56 percent in the past year, Zura Bio Limited institutional owners must be relieved by the recent gain | 04/24/2025 |
| Begin Period Cash Flow | 99.8 M |
Zura Bio Relative Risk vs. Return Landscape
If you would invest 176.00 in Zura Bio Limited on January 30, 2025 and sell it today you would lose (37.00) from holding Zura Bio Limited or give up 21.02% of portfolio value over 90 days. Zura Bio Limited is currently does not generate positive expected returns and assumes 6.5552% risk (volatility on return distribution) over the 90 days horizon. In different words, 58% of stocks are less volatile than Zura, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Zura Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zura Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zura Bio Limited, and traders can use it to determine the average amount a Zura Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0261
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ZURA |
Estimated Market Risk
| 6.56 actual daily | 58 58% of assets are less volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Zura Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zura Bio by adding Zura Bio to a well-diversified portfolio.
Zura Bio Fundamentals Growth
Zura Stock prices reflect investors' perceptions of the future prospects and financial health of Zura Bio, and Zura Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zura Stock performance.
| Return On Equity | -0.44 | ||||
| Return On Asset | -0.25 | ||||
| Current Valuation | (80.09 M) | ||||
| Shares Outstanding | 68.38 M | ||||
| Price To Book | 0.66 X | ||||
| EBITDA | (55.19 M) | ||||
| Net Income | (52.4 M) | ||||
| Total Debt | 19.51 M | ||||
| Book Value Per Share | 2.25 X | ||||
| Cash Flow From Operations | (28.08 M) | ||||
| Earnings Per Share | (0.60) X | ||||
| Market Capitalization | 96.41 M | ||||
| Total Asset | 179.53 M | ||||
| Retained Earnings | (155.9 M) | ||||
| Working Capital | 159.23 M | ||||
About Zura Bio Performance
By analyzing Zura Bio's fundamental ratios, stakeholders can gain valuable insights into Zura Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zura Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zura Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.25) | (0.24) | |
| Return On Capital Employed | (0.34) | (0.36) | |
| Return On Assets | (0.25) | (0.24) | |
| Return On Equity | (0.31) | (0.29) |
Things to note about Zura Bio Limited performance evaluation
Checking the ongoing alerts about Zura Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zura Bio Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zura Bio Limited generated a negative expected return over the last 90 days | |
| Zura Bio Limited has high historical volatility and very poor performance | |
| Zura Bio Limited may become a speculative penny stock | |
| Zura Bio Limited has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (52.4 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zura Bio generates negative cash flow from operations | |
| Zura Bio Limited has a poor financial position based on the latest SEC disclosures | |
| About 60.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: After losing 56 percent in the past year, Zura Bio Limited institutional owners must be relieved by the recent gain |
- Analyzing Zura Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zura Bio's stock is overvalued or undervalued compared to its peers.
- Examining Zura Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zura Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zura Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zura Bio's stock. These opinions can provide insight into Zura Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Zura Stock analysis
When running Zura Bio's price analysis, check to measure Zura Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zura Bio is operating at the current time. Most of Zura Bio's value examination focuses on studying past and present price action to predict the probability of Zura Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zura Bio's price. Additionally, you may evaluate how the addition of Zura Bio to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |